Literature DB >> 15982908

Accumulation of MFG-E8/lactadherin on exosomes from immature dendritic cells.

Philippe Véron1, Elodie Segura, Gaël Sugano, Sebastian Amigorena, Clotilde Théry.   

Abstract

Exosomes are vesicles of endocytic origin secreted spontaneously by dendritic cells (DCs). We have shown previously that exosomes can transfer antigen or MHC-peptide complexes between DCs, thus potentially amplifying the immune response. We had also identified milk fat globule EGF/factor VIII (MFG-E8), also called lactadherin, as one of the major exosomal proteins. MFG-E8 has two domains: an Arg-Gly-Asp sequence that binds integrins alphavbeta3 and alphavbeta5 (expressed by human DCs and macrophages) and a phosphatidyl-serine (PS) binding sequence through which it associates to PS-containing membranes (among which exosomes). MFG-E8 is thus a good candidate molecule to address exosomes to DCs. Here, we show that MFG-E8 is expressed by immature bone-marrow-derived DCs (BMDCs) and secreted in association with exosomes in vitro. We have generated mice expressing an inactive form of MFG-E8, fused to beta-galactosidase. Analyzing these mice, we demonstrate that MFG-E8 is expressed in vivo in splenic DCs. In a mouse DC-dependent, antigen-specific, CD4 T cell-stimulation assay, exosomes produced by MFG-E8-deficient BMDCs were barely less efficient than exosomes bearing MFG-E8. We conclude that MFG-E8 is efficiently targeted to exosomes but is not essential to address exosomes to mouse BMDCs. Involvement of MFG-E8/lactadherin in exosome targeting to other DC subpopulations, or to human DCs, is still possible.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15982908     DOI: 10.1016/j.bcmd.2005.05.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  44 in total

Review 1.  Exosomes: immune properties and potential clinical implementations.

Authors:  Nathalie Chaput; Clotilde Théry
Journal:  Semin Immunopathol       Date:  2010-12-21       Impact factor: 9.623

Review 2.  Membrane vesicles as conveyors of immune responses.

Authors:  Clotilde Théry; Matias Ostrowski; Elodie Segura
Journal:  Nat Rev Immunol       Date:  2009-06-05       Impact factor: 53.106

Review 3.  Regulation of immune responses by extracellular vesicles.

Authors:  Paul D Robbins; Adrian E Morelli
Journal:  Nat Rev Immunol       Date:  2014-03       Impact factor: 53.106

Review 4.  Exosomes and other extracellular vesicles in host-pathogen interactions.

Authors:  Jeffrey S Schorey; Yong Cheng; Prachi P Singh; Victoria L Smith
Journal:  EMBO Rep       Date:  2014-12-08       Impact factor: 8.807

5.  Stabilization of exosome-targeting peptides via engineered glycosylation.

Authors:  Michelle E Hung; Joshua N Leonard
Journal:  J Biol Chem       Date:  2015-02-05       Impact factor: 5.157

Review 6.  Extracellular Vesicles Exploit Viral Entry Routes for Cargo Delivery.

Authors:  Helena M van Dongen; Niala Masoumi; Kenneth W Witwer; D Michiel Pegtel
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-02       Impact factor: 11.056

Review 7.  Extracellular vesicles regulate immune responses and cellular function in intestinal inflammation and repair.

Authors:  Triet M Bui; Lorraine A Mascarenhas; Ronen Sumagin
Journal:  Tissue Barriers       Date:  2018-02-09

8.  Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages.

Authors:  Kamran Atabai; Sina Jame; Nabil Azhar; Alex Kuo; Michael Lam; William McKleroy; Greg Dehart; Salman Rahman; Dee Dee Xia; Andrew C Melton; Paul Wolters; Claire L Emson; Scott M Turner; Zena Werb; Dean Sheppard
Journal:  J Clin Invest       Date:  2009-11-02       Impact factor: 14.808

Review 9.  SED1/MFG-E8: a bi-motif protein that orchestrates diverse cellular interactions.

Authors:  Adam Raymond; Michael A Ensslin; Barry D Shur
Journal:  J Cell Biochem       Date:  2009-04-15       Impact factor: 4.429

10.  Exosomes in tumour immunity.

Authors:  A Clayton; M D Mason
Journal:  Curr Oncol       Date:  2009-05       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.